115 results
8-K
EX-99.1
dmrbogn43xrs
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.2
xwdjyhfssw3ex06xh
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-99.1
344zkxwsnj88f876
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
EX-99.2
b18viexzmos 95dw
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.1
4oxv4
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
yntxdu 7icc5r11k
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
wjsf3uhlvnyz6zv3kt
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
3oxjy gehsr8u4v
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
3az qylkh
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
f8ogn01d
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
u113up89kw
16 Jun 23
Business combination disclosure
5:17pm
425
xer3o iqm7fq
16 Jun 23
Business combination disclosure
5:16pm
425
9by pog93ifc57va3
16 Jun 23
Business combination disclosure
5:14pm